1673-422X
2012 Issue 4
Therapy for malignant glioma
XIAO Feng;WANG Hong-lin;LI Yun-hai
XIAO Feng;WANG Hong-lin;LI Yun-hai
..............page:262-264
VEGF in the treatment and prognosis of lung cancer
ZHAO Qiu;GUO Ren-hua
ZHAO Qiu;GUO Ren-hua
..............page:286-288
Factor analysis of lower extremity deep venous thrombosis after gynecologic oncology surgery
QU Hua-yan;SUN Hong-li
QU Hua-yan;SUN Hong-li
..............page:299-301
Molecular targeted therapy of diffuse large B cell lymphoma
YANG Guo-rong;ZHONG Mei-zuo
YANG Guo-rong;ZHONG Mei-zuo
..............page:311-315
..............page:245,264,281,285,315,320,后插2
Correlation between lysyl oxidase-like protein 2 and neoplasms and its mechanism
WU Fen-ping;YANG Zhi-xiong
WU Fen-ping;YANG Zhi-xiong
..............page:246-248
Peripheral blood circulating RNA and cancer diagnosis
ZHUANG Shan-shan;FANG Yu-sen;CHEN Jiong-yu
ZHUANG Shan-shan;FANG Yu-sen;CHEN Jiong-yu
..............page:243-245
Epigenetic regulation and gastric cancer
CHEN Ji;LIU Ding-yi
CHEN Ji;LIU Ding-yi
..............page:292-295
Experimental study of emodin inducing apoptosis of bile duct carcinoma cell QBC939
LI Xin-xing;WANG Jian
LI Xin-xing;WANG Jian
..............page:316-320
MiRNA and the proliferation and metastasis of breast cancer cells
CHEN Xiao-lan;QIN Shu-pei;YANG Jian-xin
CHEN Xiao-lan;QIN Shu-pei;YANG Jian-xin
..............page:265-268
Influence of bevacizumab on the invasion of glioma and the mechanism
DAI Li-ming;LI Zhi-qiang
DAI Li-ming;LI Zhi-qiang
..............page:259-261
Ku proteins and tumor radiosensitivity
LI Tian-qian;YU Shu-hui;LI Guo-miao;LI Wen-hui
LI Tian-qian;YU Shu-hui;LI Guo-miao;LI Wen-hui
..............page:249-251
Targeted treatment strategies for patients with trastuzumab-resistant HER2-overexpressing breast cancer
ZHOU Zheng-shi;LIAO Xiao-fang
ZHOU Zheng-shi;LIAO Xiao-fang
..............page:278-281
MiRNA and non-small cell lung cancer
HE Yan;LIU Yi-min
HE Yan;LIU Yi-min
..............page:282-285
Surgical treatment of lung cancer in the elderly
TAN Yuan-yuan;ZOU Xin-xin;XIE Yang;ZHANG Lei
TAN Yuan-yuan;ZOU Xin-xin;XIE Yang;ZHANG Lei
..............page:289-291
Obesity and breast cancer
CAO Heng;XIE Xiao-dong;LIU Zhao-zhe
CAO Heng;XIE Xiao-dong;LIU Zhao-zhe
..............page:268-271
Polyinosinic-polycytidylic acid and tumor immunity
CHENG Yu-sheng;XIA Jing-yan;XU Feng
CHENG Yu-sheng;XIA Jing-yan;XU Feng
..............page:252-254
Mechanism and application of natural killer cell-based adoptive immunotherapy in hematologictumor
DUAN Pei-xia;SU Li-ping
DUAN Pei-xia;SU Li-ping
..............page:304-307
Gene mutations and the phenotype of BCR/ABL-negative myeloproliferative neoplasms
FENG Xiu;OUYANG Jian;ZHOU Min
FENG Xiu;OUYANG Jian;ZHOU Min
..............page:307-310
Variations of biomarkers in gastrointestinal stromal tumor and prognoses of the patients and targeted drug sensitivity
SUN Wen;CHEN Jin-fei
SUN Wen;CHEN Jin-fei
..............page:295-298
Tumor microenvironment and neoadjuvant chemotherapy in breast cancer
RONG Guo-hua;KANG Hua
RONG Guo-hua;KANG Hua
..............page:272-274
Resistance mechanisms of trastuzumab and treatment strategies in patients with breast cancer
DING Guo-yu;LIU Xiao
DING Guo-yu;LIU Xiao
..............page:274-277
Allogeneic stem cell transplantation in multiple myeloma
ZHOU Shi-qiu;LOU Shi-feng;LUO Yun
ZHOU Shi-qiu;LOU Shi-feng;LUO Yun
..............page:301-304
The anti-tumor mechanism of (-)-epigallocatechin-3-gallate
HE Li;TANG Xu-dong
HE Li;TANG Xu-dong
..............page:255-259